Welcome to our dedicated page for Ares Management Corporation news (Ticker: $ARES), a resource for investors and traders seeking the latest updates and insights on Ares Management Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ares Management Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ares Management Corporation's position in the market.
Ares Capital (ARCC) has priced a public offering of $850 million 5.950% unsecured notes due 2029. The notes mature on July 15, 2029, with options for redemption. Various institutions are involved in managing the offering. The proceeds will be used to repay existing debt and for general corporate purposes, including investments in portfolio companies.
Ares Management (NYSE:ARES) announced closing approximately $9.3 billion in U.S. direct lending commitments in Q1 2024 and $29.6 billion in the 12 months ended March 31, 2024. Notable transactions include support for Aptean, Ardonagh Group, Artivion, Banyan Software Holdings, BMI, Clarience Technologies, CSI, ENTRUST Solutions Group, Equinox Holdings, Nelipak Healthcare Packaging, Premise Health, and The Ultimus Group.
Ares Management (NYSE:ARES) reported strong financial results for the first quarter ended March 31, 2024. The GAAP net income was $73.0 million, with a per share income of $0.33. Fee related earnings were $301.7 million, showing significant growth in assets under management and fundraising. The company declared a quarterly dividend of $0.93 per share. Ares has a Dividend Reinvestment Program for its Class A common stockholders. An earnings presentation and conference call are scheduled to discuss the results.
Ares Capital announced its Q1 2024 financial results with a dividend of $0.48 per share for Q2 2024. The company reported a strong start to the year with increased earnings, low non-accruals, and moderate leverage. Ares Capital made $3.6 billion in new investment commitments in Q1 2024 and continues to support growth in existing portfolio companies. The company remains well-positioned with available capital and competitive advantages.
